Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: Distribution and clinical outcomes
Ohad Benjamini, Preetesh Jain, Long Trinh, Wei Qiao, Sara S. Strom, Susan Lerner, Xuemei Wang, Jan Burger, Alessandra Ferrajoli, Hagop Kantarjian, Susan O'Brien, William Wierda, Zeev Estrov, Michael Keating*
Research output: Contribution to journal › Article › peer-review
130Scopus
citations
Fingerprint
Dive into the research topics of 'Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: Distribution and clinical outcomes'. Together they form a unique fingerprint.